EQUITY AND EARNINGS PER SHARE (Details Narrative) (USD $)
In Thousands, except Share data, unless otherwise specified |
1 Months Ended | 3 Months Ended | 9 Months Ended | 9 Months Ended | 0 Months Ended | 1 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
Feb. 28, 2013
|
Jan. 31, 2013
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Jun. 05, 2013
|
Dec. 31, 2012
|
Sep. 30, 2013
Stock Options
|
May 15, 2013
Manager
|
Jun. 30, 2013
Manager
|
Feb. 28, 2013
Manager
|
Jan. 31, 2013
Manager
|
Sep. 30, 2013
Former Newcastle CEO
|
|
Common stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||
Common stock, shares authorized | 1,000,000,000 | 1,000,000,000 | 500,000,000 | 500,000,000 | |||||||||||
Preferred stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||
Preferred stock, shares authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | |||||||||||
Issuance of Common Stock | $ 197,600 | $ 237,400 | $ 526,200 | $ 961,569 | |||||||||||
Issuance of Common Stock, shares | 40,250,000 | 23,000,000 | 57,500,000 | 120,963,336 | 750,000 | 191,000 | 213,900 | ||||||||
Share price | $ 4.92 | $ 10.34 | $ 9.35 | $ 4.97 | $ 10.48 | $ 9.35 | |||||||||
Options to purchase shares of common stock granted during the period | 4,025,000 | 2,300,000 | 5,750,000 | ||||||||||||
Fair value of options granted | $ 3,800 | $ 8,400 | $ 18,000 | ||||||||||||
Exercise price of options granted | $ 4.97 | $ 10.48 | $ 9.35 | ||||||||||||
Risk free rate in valuing options granted to manager | 2.50% | 2.10% | 2.00% | ||||||||||||
Dividend yield in valuing options granted to manager | 8.80% | 7.80% | 8.80% | ||||||||||||
Volatility in valuing options granted to manager | 36.90% | 55.50% | 56.20% | ||||||||||||
Expected term in valuing options granted to manager | 10 years | 10 years | 10 years | ||||||||||||
Stock options converted in spin-off | 21,500,000 | ||||||||||||||
Annual director awards granted, per director | $ 50,000 | ||||||||||||||
Annual director awards granted, per director, shares | 9,025 | ||||||||||||||
Options exercised | 307,833 | ||||||||||||||
Weighted average exercise price | $ 2.56 | ||||||||||||||
Shares issued in option exercise | 162,896 | ||||||||||||||
Aggregate intrinsic value of options net exercise price | $ 900 | ||||||||||||||
Unvested Options forfeited | 192,167 | ||||||||||||||
Vested Options forfeited | 2,170 | ||||||||||||||
Dilutive Common Stock Equivalents | 7,654,026 | 2,191,363 | 6,264,696 | 1,249,474 | 2,388,729 |
X | ||||||||||
- Definition
Number of vested options forfeited. No definition available.
|
X | ||||||||||
- Definition
Number of shares issued during the period as a result of the exercise of options (or share units) during the current period. No definition available.
|
X | ||||||||||
- Definition
Number of options held by FIG LLC, the Manager, or by its directors, officers or employees, that were converted into an adjusted Newcastle option and a new New Residential option at the spin-off of New Residential. No definition available.
|
X | ||||||||||
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Risk-free interest rate assumption used in valuing an instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net number of non-option equity instruments granted to participants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of non-vested options forfeited. No definition available.
|
X | ||||||||||
- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
X | ||||||||||
- Definition
Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Price of a single share of a number of saleable stocks of a company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued as consideration for cash for development stage entities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of shares issued as consideration for cash for development stage entities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|